Frontiers of Transplantation in Children

Sunday, April 30, 2023

8:00 AM – 9:30 AM ET

Location: Convention Center: 201

CE: Live CME: 1.50

Selected By: ASPN Independent

Chair(s)

Nicole Hayde, MD, MS

Associate Professor of Pediatrics
The Children's Hospital at Montefiore
Bronx, New York, United States

Moderator(s)

EB

Eric Benz, MD (he/him/his)

Assistant Professor of Pediatrics
University of Colorado School of Medicine
Aurora, Colorado, United States

Disclosure(s):

Nicole Hayde, MD, MS: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Eric Benz, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Session

Description: Brief Description of Overall Session: This session is targeted at pediatric nephrologists to apprise them of newer developments in kidney transplantation in children. It will provide an overview of advances in organ allocation and immunosuppression agents.

Topic/title: The Role of APOL1 in Organ Allocation and Living Donor Evaluation

Objective: To discuss the implications of utilizing APOL1 in selecting a donor for pediatric kidney transplant candidates

Topic/title: Novel ways to increase donor pool for pediatric kidney transplant candidates

Objective: To discuss various ways to increase donor pool for children (using national kidney donor exchange programs, using A2 donors for blood group B recipients, using DCD donors and PHS high risk donors)

Topic/title: Multi-Organ Transplant involving the kidney

Objective: To detail the approach for evaluating children with kidney disease with multiple organ involvment

Learning Objectives:

Understand the role of APOL1 in organ allocation and novel ways to expand donor pool for children in need of renal transplant.
Recognize the role of newer immunosuppressive agents to promote adherence and improve outcomes in pediatric kidney transplant recipients.
Describe the role of liver-kidney, kidney alone or liver alone transplant in complex ARPKD patients with different phenotypes

Presentations:

8:00 AM – 8:20 AM ET

The Role of APOL1 in Organ Allocation and Living Donor Evaluation
Speaker: Marva Moxey-Mims, MD (she/her/hers) – Children's National Hospital
8:20 AM – 8:40 AM ET

Novel ways to increase donor pool for pediatric kidney transplant candidates
Speaker: Rouba Garro, MD – Emory University School of Medicine
8:40 AM – 9:00 AM ET

Belatacept and sirolimusin maintenance immunosuppression
Speaker: Eileen Chambers, MD (she/her/hers) – Duke University
9:00 AM – 9:20 AM ET

Multi-Organ Transplant involving the kidney
Speaker: Rachel M. Engen, MD, MS – University of Wisconsin Madison
9:20 AM – 9:30 AM ET

Q&A
Moderator: Eric Benz, MD (he/him/his) – University of Colorado School of Medicine